Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units

Asian Journal of Transfusion Science

Volumn 5, Issue 2, 2011, Pages 140-143

  Kishore, Janak ^a   Srivastava, Manisha ^a   Choudhury, Nabajyoti ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

B19; blood transfusion; parvovirus; seroconversion; thalassemia

Indexed keywords

EID: 84879193054     PISSN: 09736247     EISSN: 19983565     Source Type: Journal    
DOI: 10.4103/0973-6247.83239     Document Type: Article

References (24)

1. Kishore J, Kapoor A. Erythrovirus B19 infections in humans. Indian J Med Res 2000;112:149-64.
2. Brown KE. The expanding range of parvoviruses which infect humans. Rev Med Virol 2010;20:231-44.
3. Lefrére JJ, Maniez-Montreuil M, Morel P, Defer C, Laperche S. Safety of blood products and B19 parvovirus. Transfus Clin Biol 2006;13:235-41. (Pubitemid 44820912)
4. Alter HJ, Stramer SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol 2007;44:32-41. (Pubitemid 46013927)
5. Ragni MV, Sherman KE, Jordan JA. Viral pathogens. Haemophilia 2010;16 Suppl 5:40-6.
6. Moosely JW. Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clott ing factor concentrates? Transfusion 1994;34:744-6.
7. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009;49 Suppl 2:S1-29.
8. Groner A. Pathogen safety of plasma-derived products - Haemate P/Humate-P. Haemophilia 2008;14 Suppl 5:54-71.
9. Yu MY, Alter HJ, Virata-Theimer ML, Geng Y, Ma L, Schechterly CA, et al. Parvovirus B19 infection transmitt ed by transfusion of red blood cells confi rmed by molecular analysis of linked donor and recipient samples. Transfusion 2010;50:1712-21.
10. Zanella A, Rossi F, Cesana C, Foresti A, Nador F, Binda AS, et al. Transfusion-transmitt ed human parvovirus B19 infection in a thalassemic patient. Transfusion 1995;35:769-72.
11. Regaya F, Oussaief L, Bejaoui M, Karoui M, Zili M, Khelifa R. Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia. BMC Infect Dis 2007;7:123.
12. Langar H, Triki H, Gouider E, Bahri O, Djebbi A, Sadraoui A, et al. Blood-transmitt ed viral infections among haemophiliacs in Tunisia. Transfus Clin Biol 2005;12:301-5. (Pubitemid 41400244)
13. Blümel J, Schmidt I, Effenberger W, Seitz H, Willkommen H, Brackmann HH, et al. Parvovirus B19 transmission by heat-treated clott ing factor concentrates. Transfusion 2002;42:1473-81.
14. Satake M, Hoshi Y, Taira R, Momose SY, Hino S, Tadokoro K. Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion 2011. [In press].
15. Rollag H, Patou G, Pattison JR. Prevalence of antibodies to parvovirus B 19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools. Scand J Infect Dis 1990;23:675-9.
16. Schneider B, Becker M, Brackmann HH, Eis-Hübinger AM. Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2. Thromb Haemost 2004;92:838-45. (Pubitemid 39402918)
17. Frotscher B, Salignac S, Morlon L, Bonmati C, Jeulin H, Venard V, et al. Neutropenia and / or thrombocytopenia due to acute parvovirus B19 infection. Ann Biol Clin (Paris) 2009;67:343-8.
18. Kishore J, Srivastava M, Choudhary N. Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors. Asian J Transfus Sci 2010;4:86-90.
19. Siritantikorn S, Kaewrawang S, Siritanaratkul N, Theamboonlers A, Poovorawan Y, Kantakamalakul W, et al. The prevalence and persistence of human parvovirus B19 infection in thalassemic patients. Asian Pac J Allergy Immunol 2007;25:169-74. (Pubitemid 350081448)
20. Williams MD, Cohen BJ, Beddall AC, Passi KJ, Mortimer PP, Hill FG. Transmission of human parvovirus B19 by coagulation factor concentrates. Vox Sang 1990;58:177-81. (Pubitemid 20125303)
21. Bhatt acharya DK, Bhatt acharjee S, De M, Lahiri P. Prevalence of hepatitis C in transfusion dependent thalassaemics and hemophiliacs. Indian J Med Res 1991;94:430-2.
22. Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, et al. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 2007;47:1756-64. (Pubitemid 47438539)
23. Kleinman SH, Glynn SA, Lee TH, Tobler LH, Schlumpf KS, Todd DS, et al. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood 2009;114:3677-83.
24. Menconi MC, Maggi F, Zakrzewska K, Salott i V, Giovacchini P, Farina C, et al. Effectiveness of nanofi ltration in removing small non-enveloped viruses from three different plasma-derived products. Transfus Med 2009;19:213-7.t